Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases

June 19, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search